» Articles » PMID: 19772802

Urate Oxidase (rasburicase) for Treatment of Severe Acute Gout: a Case Report

Overview
Specialty Rheumatology
Date 2009 Sep 24
PMID 19772802
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

A 73-year-old female patient was referred to our department because of gouty arthritis in the right first toe. The patient suffered from progressive renal failure because of pauci-immune necrotising glomerulonephritis. As severe hyperuricaemia would further worsen progredient renal insufficiency and therapy with allopurinol was contraindicated because of renal insufficiency and previous pancytopenia, the patient was treated twice with intravenous rasburicase. This therapy was well tolerated by the patient and led to the decrease of serum uric acid below the detection limit within 24 hours.

Citing Articles

Rasburicase Plus Methotrexate Combination Therapy in a Case of Tophaceous, Difficult-to-Treat Gout.

Pino-Zambrano M, Cardoso Penafiel P, Calvo-Aranda E Cureus. 2025; 16(12):e76265.

PMID: 39845222 PMC: 11753581. DOI: 10.7759/cureus.76265.


Managing Gout in Women: Current Perspectives.

Patel A, Gaffo A J Inflamm Res. 2022; 15:1591-1598.

PMID: 35264868 PMC: 8901224. DOI: 10.2147/JIR.S284759.


Structure-Based Immunogenicity Prediction of Uricase from Fungal (Aspergillus flavus), Bacterial (Bacillus subtillis) and Mammalian Sources Using Immunoinformatic Approach.

Tripathi S, Parmar J, Kumar A Protein J. 2020; 39(2):133-144.

PMID: 32221804 DOI: 10.1007/s10930-020-09886-0.


Pegloticase for chronic gout.

Anderson A, Singh J Cochrane Database Syst Rev. 2010; (3):CD008335.

PMID: 20238366 PMC: 6599816. DOI: 10.1002/14651858.CD008335.pub2.